titanium dioxide + titanium peroxide + titanium salicylate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
titanium dioxide + titanium peroxide + titanium salicylate: clinical details
Prescribing considerations
- Licensed specifically for treating nappy rash.
- Assess persistent, spreading or unusually severe inflammation for fungal or bacterial infection or another dermatosis.
- The selected eMC presentation is marked as discontinued.
Contraindications and cautions
- Hypersensitivity to any active ingredient or excipient.
- For external use only; avoid accidental ingestion.
Monitoring
- Review clinical response and local irritation.
- Reassess worsening, spreading or unresponsive rash.
- Urgently assess accidental ingestion or excessive application for possible salicylate toxicity.
Clinical pharmacology
Titanium salts in a water-repellent, siliconised ointment base form a tenacious non-occlusive protective film, reducing irritation from repeated hydration. The topical action resembles that of zinc oxide preparations.
Formulation and product differences
- Ointment for topical administration.
- Excipients include dimethicone, light liquid paraffin, tincture of benzoin and white soft paraffin.
- The selected product is marked as discontinued on eMC.
titanium dioxide + titanium peroxide + titanium salicylate interactions
No interactions with other medicines are known from the product information. Ask a pharmacist before combining products on the same affected skin.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.